En Es
Categorías

CHEMBIO DIAGNOSTIC SYSTEMS

Chembio develops, manufactures and commercializes diagnostic solutions and products for the rapid and early detection of HIV and syphilis at the point of care. It has products on the market in over 40 countries and seeks to develop new products to enable early and improved treatment of malaria, Ebola, febrile illness ...
Productos Covid-19NoticiasResumen
Close

Covid-19 CHEMBIO DIAGNOSTIC SYSTEMS

Laboratorio clínico

COVID-19/Flu Rapid Test
Status COVID-19/Flu

The Status COVID-19/Flu is the only FDA EUA visual read rapid test for the simultaneous detection and differential diagnosis of SARS-CoV-2, Influenza Type A & Influenza Type B Antigen in nasopharyngeal swab specimens.
Mas detalles

SARS-CoV-2 Antigen Rapid Test
DPP SARS-CoV-2 Antigen

The DPP SARS-CoV-2 Antigen is a CE Marked rapid test for the detection of nucleocapsid protein antigen to SARS-CoV-2 in nasal swab specimens. The results can either be read visually, with our DPP Micro Reader or our DPP Micro Reader II.
Mas detalles

Digital Reader
DPP Micro Reader

The DPP Micro Reader is a handheld device that enables testing for SARS-CoV-2 and other DPP tests. The maintenance free reader streamlines the point-of-care testing experience with precise and accurate results, minimizing human errors due to visual interpretation.
Mas detalles

Digital Reader
DPP Micro Reader II

The DPP Micro Reader II is a handheld device that enables testing for SARS-CoV-2 and streamlines the point-of-care testing experience with precise and accurate results. The maintenance free reader delivers automated results in 15-20 seconds and minimizes human errors due to visual interpretation.
Mas detalles

COVID-19 IgM/IgG Test
DPP COVID-19 IgM/IgG System

The DPP COVID-19 IgM/IgG System is an ANVISA Approved rapid test for the detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in capillary “fingerstick” whole blood, venous whole blood, serum and plasma samples. A simple to use, handheld, portable DPP Micro Reader provides simultaneous and separate detection of IgM and IgG antibodies to SARS-CoV-2 in 15 minutes using a small sample size of only 10 μL.
Mas detalles
Close

Noticias of CHEMBIO DIAGNOSTIC SYSTEMS

Chembio Diagnostics Announces Two New Senior-Level Appointments

25 Oct 2016
Chembio Diagnostics Announces Two New Senior-Level Appointments
Chembio Diagnostics, Inc., which develops, manufactures, licenses and markets rapid point-of-care (POC) diagnostic tests for infectious diseases, has made two new senior-level appointments.
Más info
Close

Sobre CHEMBIO DIAGNOSTIC SYSTEMS

Chembio develops, manufactures and commercializes diagnostic solutions and products for the rapid and early detection of HIV and syphilis at the point of care. It has products on the market in over 40 countries and seeks to develop new products to enable early and improved treatment of malaria, Ebola, febrile illness, dengue fever and influenza.
Facebook Twitter Google+ Linked in
Digital Reader

Digital Reader

Modelo: DPP Micro Reader II
Solicite información

Descripción:

The DPP Micro Reader II is a handheld device that enables testing for SARS-CoV-2 and streamlines the point-of-care testing experience with precise and accurate results. The maintenance free reader delivers automated results in 15-20 seconds and minimizes human errors due to visual interpretation.

Características:

Características:

Delivers Automated Results Faster than ever before in 15-20 Seconds
Easy to Use: Two Simple Steps: 1) Insert Test Device 2) Press Operating Button
Workflow Flexibility: Run test in the lab, then insert into analyzer for results
Micro USB Connection
Runs on AA batteries or via power outlet
Minimizes human errors due to visual interpretation
Maintenance free
Minimal training Solicite información

Enviar un mensaje al proveedor

* Información requerida
* Email:
Para
CHEMBIO DIAGNOSTIC SYSTEMS ()
* Mensaje

Derecho de autor © 2000-2021 TradeMed.com. Todos los derechos reservados. | Términos y condiciones